Gender-dependent modulation of α1-adrenergic responses in rat mesenteric arteries

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 5 53-5, 2003, Pages

  McKee, Alyson P ^a   Van Riper, Dee A ^a   Davison, Cathy A ^a   Singer, Harold A ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Adrenergic receptor agonists; Cyclooxygenase; Endothelium; Gonadectomy; Serotonin; Vasoconstriction

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ALPHA 1 ADRENERGIC RECEPTOR; ARACHIDONIC ACID DERIVATIVE; CYCLOOXYGENASE 1; INDOMETACIN; PHENYLEPHRINE; SEROTONIN; SEX HORMONE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; ATTENUATION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENDOTHELIUM LESION; ENZYME ACTIVITY; HYPOTHESIS; MESENTERIC ARTERY; MODULATION; MUSCLE CONTRACTILITY; NONHUMAN; ORCHIECTOMY; OVARIECTOMY; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SMOOTH MUSCLE; SMOOTH MUSCLE CONTRACTILITY; STIMULUS; SYNTHESIS;

EID: 0037405094     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00779.2002     Document Type: Article

References (24)

1. Barber DA and Miller VM. Gender differences in endothelium-dependent relaxations do not involve NO in porcine coronary arteries. Am J Physiol Heart Circ Physiol 273: H2325-H2332, 1997.
2. Case J and Davison CA. Estrogen alters relative contributions of nitric oxide and cyclooxygenase products to endothelium-dependent vasodilation. J Pharmacol Exp Ther 291: 524-530, 1999.
3. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, and Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24: 471-476, 1994.
4. Davidge ST and McLaughlin MK. Endogenous modulation of the blunted adrenergic response in resistance-sized mesenteric arteries from the pregnant rat. Am J Obstet Gynecol 167: 1691-1698, 1992.
5. 2 receptors induced by a platelet derived supernatant. Biochem Pharmacol 36: 1913-1917, 1987.
6. Freedman RR and Girgis R. Effects of menstrual cycle and race on peripheral vascular alpha-adrenergic responsiveness. Hypertension 35: 795-799, 2000.
7. Geary GG, Krause DN, and Duckles SP. Gonadal hormones affect diameter of male rat cerebral arteries through endothelium-dependent mechanisms. Am J Physiol Heart Circ Physiol 279: H610-H618, 2000.
8. Huang A, Sun D, Koller A, and Kaley G. Gender difference in flow-induced dilation and regulation of shear stress: role of estrogen and nitric oxide. Am J Physiol Regul Integr Comp Physiol 275: R1571-R1577, 1998.
9. Kahonen M, Tolvanen JP, Sallinen K, Wu X, and Porsti I. Influence of gender on control of arterial tone in experimental hypertension. Am J Physiol Heart Circ Physiol 275: H15-H22, 1998.
10. Majmudar NG, Robson SC, and Ford GA. Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. J Clin Endocrinol Metab 85: 1577-1583, 2000.
11. McNeill AM, Zhang C, Stanczyk FZ, Duckles SP, and Krause DN. Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels: effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone. Stroke 33: 1685-1691, 2002.
12. Mendelsohn ME and Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801-1811, 1999.
13. Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, Graneto MJ, Lee LF, Malecha JW, Miyashiro JM, Rogers RS, Rogier DJ, Yu SS, Anderson GD, Burton EG, Cogburn JN, Gregory SA, Koboldt CM, Perkins WE, Seibert K, Veenhuizen AW, Zhang YY, and Isakson PC. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide (SC-58635, celecoxib). J Med Chem 40: 1347-1365, 1997.
14. Perregaux D, Chaudhuri A, Mohanty P, Bukhari L, Wilson MF, Sung BH, and Dandona P. Effect of gender differences and estrogen replacement therapy on vascular reactivity. Metabolism 48: 227-232, 1999.
15. Rubanyi GM, Freay AD, Kauser K, Sukovich D, Burton G, Lubahn DB, Couse JF, Curtis SW, and Korach KS. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption. J Clin Invest 99: 2429-2437, 1997.
16. Sader MA and Celermajer DS. Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovasc Res 53: 597-604, 2002.
17. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, Talley JJ, Mansferrer JL, Seibert K, and Isakson PC. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 95: 133313-13318, 1998.
18. Stallone JN. Role of endothelium in sexual dimorphism in vasopressin-induced contraction of rat aorta. Am J Physiol Heart Circ Physiol 265: H2073-H2080, 1993.
19. Sullivan JC and Davison CA. Gender differences in the effect of age on electrical field stimulation (EFS)-induced adrenergic vasoconstriction in rat mesenteric resistance arteries. J Pharmacol Exp Ther 296: 782-788, 2001.
20. 1-adrenoreceptor-mediated constriction of arterioles. Am J Physiol Heart Circ Physiol 281: H873-H881, 2001.
21. + channels. Circ Res 79: 24-30, 1996.
22. White RM, Rivera CO, and Davison CA. Nitric oxide-dependent and -independent mechanisms account for gender differences in vasodilation to acetylcholine. J Pharmacol Exp Ther 292:375-380, 2000.
23. Wu Y, Huang A, Sun D, Falck JR, Koller A, and Kaley G. Gender-specific compensation for the lack of NO in the mediation of flow-induced arteriolar dilation. Am J Physiol Heart Circ Physiol 280: H2456-H2461, 2001.
24. Zhang Y and Davidge ST. Effect of estrogen replacement on vasoconstrictor responses in rat mesenteric arteries. Hypertension 34: 1117-1122, 1999.